Henry Schein (NASDAQ:HSIC) Reaches New 52-Week Low – Here’s What Happened

Henry Schein, Inc. (NASDAQ:HSIC)’s stock price reached a new 52-week low during trading on Friday . The company traded as low as $63.00 and last traded at $63.93, with a volume of 99296 shares traded. The stock had previously closed at $66.59.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on HSIC. UBS Group cut their price objective on shares of Henry Schein from $83.00 to $80.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 26th. Wells Fargo & Company assumed coverage on shares of Henry Schein in a research note on Friday, February 14th. They issued an “equal weight” rating and a $80.00 price objective for the company. Barrington Research reissued an “outperform” rating and set a $90.00 target price on shares of Henry Schein in a research report on Wednesday, February 26th. Bank of America upgraded Henry Schein from an “underperform” rating to a “buy” rating and upped their price target for the stock from $69.00 to $84.00 in a research note on Monday, January 6th. Finally, Jefferies Financial Group raised their price objective on Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a research note on Thursday, January 23rd. Six investment analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $81.10.

Henry Schein Trading Down 1.7 %

The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. The company has a market capitalization of $8.13 billion, a price-to-earnings ratio of 26.94, a price-to-earnings-growth ratio of 2.13 and a beta of 0.84. The business has a fifty day moving average price of $73.96 and a 200 day moving average price of $72.58.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.04). Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The company had revenue of $3.19 billion during the quarter, compared to the consensus estimate of $3.25 billion. During the same period last year, the company earned $0.66 earnings per share. Henry Schein’s revenue for the quarter was up 5.8% on a year-over-year basis. On average, equities analysts expect that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Insider Buying and Selling at Henry Schein

In related news, Director Philip A. Laskawy sold 2,604 shares of the stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total value of $184,988.16. Following the completion of the transaction, the director now owns 24,805 shares of the company’s stock, valued at $1,762,147.20. This represents a 9.50 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Bradford C. Connett sold 4,036 shares of the firm’s stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total transaction of $287,161.40. Following the transaction, the chief executive officer now owns 62,688 shares of the company’s stock, valued at approximately $4,460,251.20. This represents a 6.05 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.14% of the company’s stock.

Hedge Funds Weigh In On Henry Schein

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Invesco Ltd. grew its position in Henry Schein by 0.4% in the fourth quarter. Invesco Ltd. now owns 4,963,409 shares of the company’s stock valued at $343,468,000 after acquiring an additional 17,552 shares during the period. FMR LLC grew its holdings in shares of Henry Schein by 6.6% in the 4th quarter. FMR LLC now owns 3,498,033 shares of the company’s stock worth $242,064,000 after purchasing an additional 217,143 shares during the last quarter. Geode Capital Management LLC increased its position in shares of Henry Schein by 0.5% during the 4th quarter. Geode Capital Management LLC now owns 3,169,033 shares of the company’s stock worth $218,762,000 after purchasing an additional 14,876 shares in the last quarter. Palestra Capital Management LLC acquired a new position in Henry Schein in the fourth quarter valued at about $182,988,000. Finally, Fiduciary Management Inc. WI grew its stake in Henry Schein by 7.2% during the fourth quarter. Fiduciary Management Inc. WI now owns 2,488,335 shares of the company’s stock worth $172,193,000 after buying an additional 167,990 shares during the last quarter. Institutional investors own 96.62% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.